Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 9:20 PM UTC
| NCT Number | NCT05355701 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE1 |
| Target Enrollment | 267 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 31, 2026 (4 weeks ago) |
As of August 29, 2026: Clinical trial NCT05355701 is currently recruiting participants. This phase1 study for melanoma is actively seeking new participants at 31 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05355701 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05355701 was last updated 4 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.